Frazier Life Sciences Management, L.P.
Position in MAZE — Maze Therapeutics, Inc.
CIK 1892134
PALO ALTO, CA
Position in MAZE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$150,182,183
+$13,849,055 QoQ
Shares Held
5,032,915
+10.2% QoQ
Ownership
9.06%
of shares outstanding
% of Portfolio
3.27%
of 13F equity value
Holder Rank
#1
of 161 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MAZE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Frazier Life Sciences Management, L.P. holds $4,497,017,185 across 37 Biotechnology names. MAZE ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
7,679,684 | $899,060,605 | |
| 2 | NAMS |
NewAmsterdam Pharma Co N.V.
|
18,589,235 | $623,725,004 | |
| 3 | ERAS |
Erasca, Inc.
|
24,975,188 | $457,545,444 | |
| 4 | MBX |
MBX Biosciences, Inc.
|
6,652,013 | $367,191,117 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
9,874,511 | $258,909,678 | |
| 6 | TRVI |
Trevi Therapeutics, Inc.
|
9,939,447 | $185,370,686 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
481,307 | $178,887,372 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
This page
|
5,032,915 | $150,182,183 |
All Filings in MAZE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $150,182,183 | 5,032,915 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $136,333,128 | 4,567,274 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $189,222,161 | 4,567,274 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $118,429,414 | 4,567,274 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $56,040,464 | 4,567,275 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $45,460,301 | 4,129,001 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||